PAM
RVMD icon

Panagora Asset Management’s Revolution Medicines RVMD Stock Holding History

Panagora Asset Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-418
Closed -$13K – 2752
2020
Q2 		$13K Buy
+418
New +$13.1K ﹤0.01% 2213

Other funds holding RVMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Panagora Asset Management's RVMD Position: Q3 2020 in Review

Panagora Asset Management sold out of Revolution Medicines (RVMD) in Q3 2020, closing a stake of 418 shares — an estimated $13K sold.

Panagora Asset Management first reported a position in RVMD in Q2 2020 and held it in 1 quarter. The position peaked at $13K in Q2 2020. 90 funds tracked by Wall St. Rank hold RVMD as of Q3 2020.

  • Panagora Asset Management reported no remaining Revolution Medicines position as of Q3 2020 after selling out during the quarter.
  • Panagora Asset Management sold 418 Revolution Medicines shares in Q3 2020, an estimated $13K.
  • Panagora Asset Management first reported a position in Revolution Medicines in Q2 2020 and held it in 1 quarter.
  • Panagora Asset Management's Revolution Medicines position peaked at $13K in Q2 2020.
  • 90 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2020.

Based on Panagora Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.